Spero Therapeutics
SPRO
SPRO
48 hedge funds and large institutions have $20.6M invested in Spero Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
20% less funds holding
Funds holding: 60 → 48 (-12)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
79% less call options, than puts
Call options by funds: $30K | Put options by funds: $145K
Holders
48
Holding in Top 10
1
Calls
$30K
Puts
$145K
Top Buyers
| 1 | +$540K | |
| 2 | +$472K | |
| 3 | +$159K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$118K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$117K |
Top Sellers
| 1 | -$554K | |
| 2 | -$498K | |
| 3 | -$329K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$60.3K |
| 5 |
VF
Virtu Financial
New York
|
-$59K |